184 related articles for article (PubMed ID: 35080151)
1. Antibodies to Cartilage Oligomeric Matrix Protein Are Pathogenic in Mice and May Be Clinically Relevant in Rheumatoid Arthritis.
Ge C; Tong D; Lönnblom E; Liang B; Cai W; Fahlquist-Hagert C; Li T; Kastbom A; Gjertsson I; Dobritzsch D; Holmdahl R
Arthritis Rheumatol; 2022 Jun; 74(6):961-971. PubMed ID: 35080151
[TBL] [Abstract][Full Text] [Related]
2. Cartilage oligomeric matrix protein specific antibodies are pathogenic.
Geng H; Nandakumar KS; Pramhed A; Aspberg A; Mattsson R; Holmdahl R
Arthritis Res Ther; 2012 Aug; 14(4):R191. PubMed ID: 22906101
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity.
Söderlin MK; Kastbom A; Kautiainen H; Leirisalo-Repo M; Strandberg G; Skogh T
Scand J Rheumatol; 2004; 33(3):185-8. PubMed ID: 15228190
[TBL] [Abstract][Full Text] [Related]
4. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
[TBL] [Abstract][Full Text] [Related]
5. Human monoclonal rheumatoid synovial B lymphocyte hybridoma with a new disease-related specificity for cartilage oligomeric matrix protein.
Souto-Carneiro MM; Burkhardt H; Müller EC; Hermann R; Otto A; Kraetsch HG; Sack U; König A; Heinegård D; Müller-Hermelink HK; Krenn V
J Immunol; 2001 Mar; 166(6):4202-8. PubMed ID: 11238672
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to human cartilage oligomeric matrix protein: epitope mapping and characterization of sandwich ELISA.
Vilím V; Vobůrka Z; Vytásek R; Senolt L; Tchetverikov I; Kraus VB; Pavelka K
Clin Chim Acta; 2003 Feb; 328(1-2):59-69. PubMed ID: 12559599
[TBL] [Abstract][Full Text] [Related]
7. Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis.
Morozzi G; Fabbroni M; Bellisai F; Cucini S; Simpatico A; Galeazzi M
Clin Rheumatol; 2007 Aug; 26(8):1335-8. PubMed ID: 17285224
[TBL] [Abstract][Full Text] [Related]
8. Early diagnostic and prognostic values of anti-cyclic citrullinated peptide antibody and cartilage oligomeric matrix protein in rheumatoid arthritis.
Algergawy SA; Abd El-Sabour M; Osman AS; Emam SM; Elham N
Egypt J Immunol; 2013; 20(2):11-20. PubMed ID: 24617043
[TBL] [Abstract][Full Text] [Related]
9. Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis.
Happonen KE; Saxne T; Aspberg A; Mörgelin M; Heinegård D; Blom AM
Arthritis Rheum; 2010 Dec; 62(12):3574-83. PubMed ID: 20737467
[TBL] [Abstract][Full Text] [Related]
10. Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis.
Christensen AF; Lindegaard H; Hørslev-Petersen K; Hetland ML; Ejbjerg B; Stengaard-Pedersen K; Jacobsen S; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Tarp U; Pødenphant J; Østergaard M; Junker P
J Rheumatol; 2011 Aug; 38(8):1563-8. PubMed ID: 21572145
[TBL] [Abstract][Full Text] [Related]
11. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation.
Neidhart M; Hauser N; Paulsson M; DiCesare PE; Michel BA; Häuselmann HJ
Br J Rheumatol; 1997 Nov; 36(11):1151-60. PubMed ID: 9402858
[TBL] [Abstract][Full Text] [Related]
12. Enhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISA.
Lai Y; Yu XP; Zhang Y; Tian Q; Song H; Mucignat MT; Perris R; Samuels J; Krasnokutsky S; Attur M; Greenberg JD; Abramson SB; Di Cesare PE; Liu CJ
Osteoarthritis Cartilage; 2012 Aug; 20(8):854-62. PubMed ID: 22595227
[TBL] [Abstract][Full Text] [Related]
13. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
Wisłowska M; Jabłońska B
Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis.
Skoumal M; Kolarz G; Klingler A
Scand J Rheumatol; 2003; 32(3):156-61. PubMed ID: 12892252
[TBL] [Abstract][Full Text] [Related]
15. Role of Serum cartilage oligomeric matrix protein (COMP) in the diagnosis of rheumatoid arthritis (RA): A case-control study.
Liu F; Wang X; Zhang X; Ren C; Xin J
J Int Med Res; 2016 Aug; 44(4):940-9. PubMed ID: 27217240
[TBL] [Abstract][Full Text] [Related]
16. Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment.
Happonen KE; Saxne T; Geborek P; Andersson M; Bengtsson AA; Hesselstrand R; Heinegård D; Blom AM
Arthritis Res Ther; 2012 Jan; 14(1):R15. PubMed ID: 22264230
[TBL] [Abstract][Full Text] [Related]
17. Incomplete B cell tolerance to cartilage oligomeric matrix protein in mice.
Geng H; Nandakumar KS; Xiong L; Jie R; Dong J; Holmdahl R
Arthritis Rheum; 2013 Sep; 65(9):2301-9. PubMed ID: 23754310
[TBL] [Abstract][Full Text] [Related]
18. HLA DRB1* typing and cartilage oligomeric matrix protein (COMP) as predictors of joint destruction in recent-onset rheumatoid arthritis.
Wollheim FA; Eberhardt KB; Johnson U; Saxne T
Br J Rheumatol; 1997 Aug; 36(8):847-9. PubMed ID: 9291852
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic antibody response to glucose-6-phosphate isomerase targets a modified epitope uniquely exposed on joint cartilage.
Li T; Ge C; Krämer A; Sareila O; Leu Agelii M; Johansson L; Forslind K; Lönnblom E; Yang M; Xu B; Li Q; Cheng L; Bergström G; Fernandez G; Kastbom A; Rantapää-Dahlqvist S; Gjertsson I; Holmdahl R
Ann Rheum Dis; 2023 Jun; 82(6):799-808. PubMed ID: 36858822
[TBL] [Abstract][Full Text] [Related]
20. Decrement of serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis (RA) patients achieving remission after 6 months of etanercept treatment: comparison with CRP, IgM-RF, MMP-3 and anti-CCP Ab.
Kawashiri SY; Kawakami A; Ueki Y; Imazato T; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Nakamura H; Origuchi T; Ida H; Eguchi K
Joint Bone Spine; 2010 Oct; 77(5):418-20. PubMed ID: 20864374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
